WHITE PAPER
2024 Safety and Regulatory Compliance Trends and Predictions for Pharma and Biotech
An in-depth discussion on the impact of AI and regulatory changes on the pharmaceutical industry, with insights on the role of GenAI in drug development and pharmacovigilance, upcoming regulatory challenges, and the importance of integrating safety services with technology for future success.
Jan 02, 2024
Download
Uncover the evolving landscape of the pharmaceutical industry in IQVIA's white paper, "Safety & Regulatory Predictions for 2024". From interviews with our safety and regulatory experts, learn their informed predictions about the impact of cutting-edge technologies like artificial intelligence (AI) and machine learning on drug development and pharmacovigilance in the upcoming years. The white paper offers a deep-dive into the anticipated challenges and regulatory shifts and how Generative Artificial Intelligence (GenAI) is set to play a transformative role. Furthermore, it underscores the criticality of harmonizing safety services with technological advancements for overall operational efficacy and patient safety. The white paper also outlines the prospective application of AI-powered chatbots in the industry.

Related solutions

Contact Us